Anti-Parkinson Drugs by Dr.Shikha Parmar

Parkinson's Disease. Parkinson's disease is a brain disorder that leads to shaking, stiffness, and difficulty with walking, balance, and coordination. Parkinson's symptoms usually begin gradually and get worse over time. As the disease progresses, people may have difficulty walking and talking.

[@user-ph2me2ed4c]

Nice Nice Nice ...
Thank you Maam ❤❤

[@shaeestapraveen287]

Nice explained ma'am please upload more videos

[@ArvindKumar-kw7ls]

Plz upload one video on cancer and it's pathogenesis

[@drsudhanshu4261]

Thankk you ma'am...ur videos are really helpful, especially for quick revision of KDT

[@abduldilawar2235]

Excellent mam .great mam easily understood

[@DrShikhaParmarClasses]

Glad to hear that

[@ramendrakumar9522]

Thank you mam 🙏🙏

[@rukiyabashirshah6003]

Thank you so much mam ❤❤❤❤

[@24kokilae51]

Why glutamate receptor antagonist used in parkinsonism disorder mam?

[@DrShikhaParmarClasses]

Use of NMDA antagonists in Parkinson’s Disease (PD)
(1) NMDA antagonists block abnormal glutamate signals seen in the pathogenesis of Parkinson’s disease.
(2) subthreshold doses of NMDA antagonists cause enhanced release of striatal dopamine and
(3) Parkinson’s Disease models suggest that NMDA antagonism may protect nigral neurons.
It has been found that NMDA antagonism improves PD symptoms, is neuroprotective and prevent PD progression by inhibition of glutamatergic-mediated excitotoxicity.
Reference: Vanle Brigitte et al; NMDA antagonists for treating the non-motor symptoms in Parkinson’s disease; Transl Psychiatry; 2018; Vol 8: page 117.
Hope this clears your question

[@anantjauhari]

Thanks.can I talk to you ?

[@prathus6491]

Really love your way of teaching mam ❤❤❤❤❤❤❤
🫴😇💗

[@DrShikhaParmarClasses]

Thanks for watching and liking the video